Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EWTX will decline by -1.65% over the next 2 Weeks and hit $25.13 by Friday, January 2, 2026. In that time frame, EWTX's share price is expected to range between $23.81 and $26.31.
BearishAverageBullishEWTX shares fell -16.79% in Monday, December 22, 2025's trading session, dropping from a previous close of $25.55 to move at $21.26. The stock demonstrated notable intraday movement (see EWTX's key stats for a full breakdown), fluctuating between $21.19 and $25.20, a +18.95% trading range. While recent weeks have seen some volatility, EWTX has managed to secure a -9.88% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 3.12M shares changing hands, 884.88K more than the previous session. This amounted to $66.42M in total market activity.
Will EWTX Continue Its Upward Trend?
According to analyst ratings and projections for EWTX, Edgewise Therapeutics, Inc. shares are anticipated to increase by +19.29%, potentially reaching $26.34 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for EWTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the EWTX stock forecast, now is a good time to buy EWTX stock because its current trading price is -15.39% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on EWTX covering social and institutional perspectives.
EWTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EWTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.65% to 49.99%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.67%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.41%, maintains a neutral outlook for the long term. Insights into EWTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Edgewise Therapeutics Short-Term Forecasts
EWTX Forecast For Next 5 Days
Our algorithm anticipates Edgewise Therapeutics (EWTX) stock could hit $28.08 by Dec 29, 2025. This represents a +32.07% rise from today's price, following a +9.05% change over the past five days.
EWTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Edgewise Therapeutics, Inc. (EWTX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $26.82, which would mean a +26.15% increase from the current price of $21.26. Projections for this period range from a high of $31.80 to a low of $21.00.
EWTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Edgewise Therapeutics's price over the next three months point to a rise. EWTX stock is expected to peak at $29.47 on Mar 02, 2026 after potentially dipping to $22.48 on Feb 06, 2026. On average, EWTX is likely to trade around $26.09 in the coming 90 days.
Edgewise Therapeutics Stock Forecast 2025
Based on our predictive models, Edgewise Therapeutics (EWTX) is expected to trade between $22.89 and $28.62 throughout 2025. This would result in an average price of $25.91, potentially offering investors a +21.87% return from current levels.
Edgewise Therapeutics, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Edgewise Therapeutics, Inc. (EWTX) is positioned to show a strong performance in December 2025. The price is predicted to move between $22.89 and $28.62, settling at an average of $25.91. This could translate to a +21.87% gain.
January 2026
Based on current market signals, Edgewise Therapeutics, Inc. is projected to trend january 2026. We forecast a trading range from $23.33 to $29.44, with a likely average price of $26.45. Investors could expect a potential return of +24.41%.
February 2026
Our predictive algorithms indicate Edgewise Therapeutics, Inc. stock may see a shift in February 2026. The expected range spans $22.48–$29.44, with an average target of $25.68. This represents a positive outlook and a possible gain of +20.79%.
March 2026
Analyzing established trends, Edgewise Therapeutics, Inc. looks set to move in March 2026. Projections place the stock between $22.45 and $29.47, averaging around $25.90. This suggests a +21.83% gain from current levels.
April 2026
Market indicators suggest Edgewise Therapeutics, Inc. could experience notable changes during April 2026. Prices could fluctuate within $22.69 to $29.91, with a midpoint forecast of $26.42. The stock might deliver a +24.27% gain.
May 2026
Forecasting for May 2026, models estimate that Edgewise Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $23.73 and $30.78, averaging $27.24. This signals a positive trajectory with potential returns around +28.13%.
June 2026
According to our latest forecast models, Edgewise Therapeutics, Inc. (EWTX) is positioned to show a strong performance in June 2026. The price is predicted to move between $25.28 and $31.91, settling at an average of $28.48. This could translate to a +33.96% gain.
July 2026
Based on current market signals, Edgewise Therapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $24.35 to $31.76, with a likely average price of $27.85. Investors could expect a potential return of +31.00%.
August 2026
Our predictive algorithms indicate Edgewise Therapeutics, Inc. stock may see a shift in August 2026. The expected range spans $24.34–$31.08, with an average target of $27.78. This represents a positive outlook and a possible gain of +30.67%.
September 2026
Analyzing established trends, Edgewise Therapeutics, Inc. looks set to move in September 2026. Projections place the stock between $25.07 and $31.51, averaging around $28.55. This suggests a +34.29% gain from current levels.
October 2026
Market indicators suggest Edgewise Therapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $25.86 to $32.56, with a midpoint forecast of $29.45. The stock might deliver a +38.52% gain.
November 2026
Forecasting for November 2026, models estimate that Edgewise Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.84 and $40.57, averaging $30.77. This signals a positive trajectory with potential returns around +44.73%.
December 2026
According to our latest forecast models, Edgewise Therapeutics, Inc. (EWTX) is positioned to show a strong performance in December 2026. The price is predicted to move between $26.30 and $32.63, settling at an average of $29.53. This could translate to a +38.90% gain.
EWTX's history of dividends and stock splits also plays a role in long-term investor confidence.